Equities
  • Price (EUR)1.88
  • Today's Change0.01 / 0.53%
  • Shares traded50.00
  • 1 Year change-1.78%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 18:27 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year PureTech Health PLC's revenues fell -78.68% from 15.62m to 3.33m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 50.35m to a larger loss of 65.70m.
Gross margin--
Net profit margin-19,222.22%
Operating margin-29,152.56%
Return on assets-14.13%
Return on equity-19.88%
Return on investment-16.35%
More ▼

Cash flow in USDView more

In 2023, PureTech Health PLC increased its cash reserves by 27.50%, or 41.22m. Cash Flow from Financing totalled 78.14m or 2,346.58% of revenues. In addition the company used 105.92m for operations while cash from investing totalled 68.99m.
Cash flow per share-0.2435
Price/Cash flow per share--
Book value per share1.02
Tangible book value per share1.02
More ▼

Balance sheet in USDView more

PureTech Health PLC has a Debt to Total Capital ratio of 7.28%, a higher figure than the previous year's 3.89%.
Current ratio3.68
Quick ratio--
Total debt/total equity0.0761
Total debt/total capital0.0728
More ▼

Growth rates in USD

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-80.86
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.